Morgan Stanley, CVS Health And More On CNBC's 'Final Trades'
Portfolio Pulse from Lisa Levin
On CNBC's 'Halftime Report Final Trades,' experts shared their picks including U.S. 1 Year Treasury Bill, CVS Health Corporation, Morgan Stanley, and Invesco Food & Beverage ETF. CVS Health reported a 10.6% increase in Q3 sales, beating estimates, and is set for Investor Day on Dec. 5, 2023. Morgan Stanley appointed a new CEO effective Jan. 1. CVS Health, Morgan Stanley, and Invesco Food & Beverage ETF all saw positive price action on Monday.
December 05, 2023 | 2:25 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Liz Young of BNY Mellon Investment Management selected Invesco Food & Beverage ETF, which gained 0.7% during Monday's session.
While the ETF experienced a positive gain, the impact of the recommendation on the short-term price is uncertain without more specific catalysts.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
CVS Health Corporation reported a 10.6% increase in Q3 sales, surpassing estimates, and is preparing for its Investor Day on Dec. 5, 2023. The stock closed at $68.48 on Monday.
The positive earnings report and upcoming Investor Day are likely to generate investor optimism, potentially leading to a short-term increase in stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Morgan Stanley appointed Edward (Ted) Pick as CEO effective Jan. 1, and the stock gained 0.4% to $81.21 on Monday. Sarat Sethi named it as his final trade amid a pickup in market activity.
The CEO appointment and positive market activity could contribute to a favorable outlook for Morgan Stanley, potentially boosting the stock in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80